Firms

NewFund

NewFund

New York, New York · Los Angeles, California · Palo Alto, California · Menlo Park, California · Paris, France · Stanford, California · France · Nouvelle Aquitaine, France · Palo Alto, California, United States

Newfund invests in early-stage companies in Europe and the United States. Its HEKA strategy backs brain-health technologies, including digital therapies, AI diagnostics, neuroimaging and drug-delivery platforms, and helps European startups enter the US market.

Founded
—
Type
Venture capital

Funds1

  • HEKA€60M

    BrainTech venture fund supporting neurological, psychiatric and cognitive-health startups. Final close at €60 million; invests in AI, digital therapeutics, imaging and biotechnology, with a transatlantic commercialization strategy.

Team

$1M$500K – $2M
—— – —
—— – —
François Véron

NewFund, General Partner

—— – —
Henri Deshays

NewFund, General Partner

—— – —
—— – —
—— – —
Patrick Malka

NewFund, General Partner

—— – —
—— – —

Operations and support

Adama WadeFinancial Controller
Agathe DescampsRegional Development
Antoine LatrilleChief Technical Officer
Eleonore BretonChief Operating Partner
Garin PitziniChief Financial & Sustainability Officer
Leopold BourauxAI & Data Engineer
Noémie MalkaMarketing & Communications Manager
Noémie RagotFrontend Developer
Pauline BréantFinance Manager
Stéphane CardinetContent Marketing & Communications Manager
Vera DimitrovaChief Marketing Officer & Investor Relations

Co-investing

Y Combinator
  • Haiku$— · Unknown date

Investments

$—Unknown dateOria BioscienceNewFund
$—Unknown dateNureaNewFund
$—Unknown dateSoihtu DTxNewFund
$—Unknown dateAI StrokeNewFund
€3MUnknown dateDiagnolyNewFund
$—Unknown dateRaidiumNewFund
$—Unknown dateInside TherapeuticsNewFund
$—Unknown dateReevNewFund
$—Unknown dateHaikuY Combinator, NewFund